Literature DB >> 29387456

Foreword.

Andrew Js Coats1,2, Giuseppe Rosano1,2.   

Abstract

Year:  2017        PMID： 29387456      PMCID： PMC5739901          DOI： 10.15420/cfr.2017:3:2:77

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN： 2057-7540


× No keyword cloud information.
  35 in total

1.  Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?

Authors:  Muthiah Vaduganathan; Vinay Prasad
Journal:  Eur J Heart Fail       Date:  2015-12-13       Impact factor: 15.534

2.  Adding insult to injury: heart failure and incident cancer.

Authors:  Stephan von Haehling
Journal:  Eur J Heart Fail       Date:  2016-02-01       Impact factor: 15.534

3.  The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry.

Authors:  Giuseppe Di Tano; Renata De Maria; Lucio Gonzini; Nadia Aspromonte; Andrea Di Lenarda; Mauro Feola; Marco Marini; Massimo Milli; Gianfranco Misuraca; Andrea Mortara; Fabrizio Oliva; Giovanni Pulignano; Giulia Russo; Michele Senni; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2015-05-27       Impact factor: 15.534

4.  Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.

Authors:  Ann Banke; Morten Schou; Lars Videbaek; Jacob E Møller; Christian Torp-Pedersen; Finn Gustafsson; Jordi S Dahl; Lars Køber; Per R Hildebrandt; Gunnar H Gislason
Journal:  Eur J Heart Fail       Date:  2016-01-10       Impact factor: 15.534

Review 5.  Sleep-disordered breathing in heart failure.

Authors:  Simon G Pearse; Martin R Cowie
Journal:  Eur J Heart Fail       Date:  2016-02-11       Impact factor: 15.534

6.  Protective effects of spironolactone against anthracycline-induced cardiomyopathy.

Authors:  Mahmut Akpek; Ibrahim Ozdogru; Omer Sahin; Mevlude Inanc; Ali Dogan; Cevat Yazici; Veli Berk; Halit Karaca; Nihat Kalay; Abdurrahman Oguzhan; Ali Ergin
Journal:  Eur J Heart Fail       Date:  2014-11-20       Impact factor: 15.534

Review 7.  Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.

Authors:  Emilia D'Elia; Muthiah Vaduganathan; Mauro Gori; Antonello Gavazzi; Javed Butler; Michele Senni
Journal:  Eur J Heart Fail       Date:  2015-10-23       Impact factor: 15.534

8.  The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.

Authors:  Stefan Aschauer; Andreas A Kammerlander; Caroline Zotter-Tufaro; Robin Ristl; Stefan Pfaffenberger; Alina Bachmann; Franz Duca; Beatrice A Marzluf; Diana Bonderman; Julia Mascherbauer
Journal:  Eur J Heart Fail       Date:  2015-10-09       Impact factor: 15.534

9.  Concurrent depletion of skeletal muscle, fat, and left ventricular mass in patients with cirrhosis of the liver.

Authors:  Seyyed Mohammad Reza Kazemi-Bajestani; Harald Becher; Sunita Ghosh; Aldo J Montano-Loza; Vickie E Baracos
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-12-27       Impact factor: 12.910

Review 10.  Biomarkers for physical frailty and sarcopenia: state of the science and future developments.

Authors:  Riccardo Calvani; Federico Marini; Matteo Cesari; Matteo Tosato; Stefan D Anker; Stephan von Haehling; Ram R Miller; Roberto Bernabei; Francesco Landi; Emanuele Marzetti
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-07-07       Impact factor: 12.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.